These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7182435)

  • 21. Myelography with lopamidol.
    Lamb JT; Holland IM
    AJNR Am J Neuroradiol; 1983; 4(3):851-3. PubMed ID: 6410871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial of iopamidol for lumbosacral myelography.
    Drayer B; Suslavich F; Luther J; Rommel A; Allen S; Dubois P; Heinz R; Bates M
    AJNR Am J Neuroradiol; 1982; 3(1):59-64. PubMed ID: 6800240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iopamidol (B 15,000), a nonionic water-soluble contrast medium for neuroradiology. part II: results of a double-blind study of the lumbar epidural venous plexuses.
    Bacarini L; de Nicola T; Gasparini D; Orlando P; Vassallo A
    Neuroradiology; 1982; 23(3):147-52. PubMed ID: 6211636
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse side effects of metrizamide and iopamidolo in myelography.
    Carella A; Federico F; Di Cuonzo F; Vinjau E; Lamberti P
    Neuroradiology; 1982; 22(5):247-9. PubMed ID: 6174896
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cervical myelography with iopamidol].
    Bonafé A; Prère J; Bonaldi G; Marcovich Y; Lebec G; Manelfe C
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):783-8. PubMed ID: 6670840
    [No Abstract]   [Full Text] [Related]  

  • 27. [Myelography with water-soluble contrast media in the diagnosis of space-occupying spinal lesions].
    Schmidt RC
    Rontgenpraxis; 1982 May; 35(5):166-73. PubMed ID: 7089723
    [No Abstract]   [Full Text] [Related]  

  • 28. [Iopamidol: a complementary study in 42 patients with pathology indicating the need for myeloradiculography].
    Fredy D
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):793-6. PubMed ID: 6670842
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sacroradiculo graphic and myelographic investigations with iopamidol: study of 610 examinations (author's transl)].
    Caputo N; Chiurulla C; Cianciulli E; Ciorba E; Floridi P; Pelliccioli GP; Capponi O; Signorini E
    Riv Patol Nerv Ment; 1981; 102(2):56-68. PubMed ID: 7345552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outpatient lumbar myelography. Analysis of complications after myelography comparing outpatients with inpatients.
    Postacchini F; Massobrio M
    Spine (Phila Pa 1976); 1985; 10(6):567-70. PubMed ID: 4081870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with iopamidol in myeloradiculography].
    Bohutová J; Kolár J; Lerlová L; Fendrych P
    Cesk Radiol; 1984 Feb; 38(1):14-22. PubMed ID: 6713585
    [No Abstract]   [Full Text] [Related]  

  • 33. [Side effects and contrast medium resorption of iopamidol and iocarmate in lumbar myelography].
    Stoeter P; Bergleiter R; Schneider I; Kubina FG
    Computertomographie; 1982 Dec; 2(4):179-83. PubMed ID: 6821243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iopamidol and metrizamide for myelography: prospective double-blind clinical trial.
    Witwer G; Cacayorin ED; Bernstein AD; Hubballah MY; Yuan HA; Kieffer SA
    AJR Am J Roentgenol; 1984 Oct; 143(4):869-73. PubMed ID: 6382981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myeloradiculography with iopamidol and metrizamide. Comparative study].
    Bohutová J; Kolár J; Lerlová L
    Cesk Radiol; 1984 Feb; 38(1):23-7. PubMed ID: 6713587
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adverse reactions during ascending cervical myelography using iopamidol and metrizamide--a double-blind study].
    Bockenheimer S; Eichenlaub H
    Rontgenpraxis; 1986 May; 39(5):171-4. PubMed ID: 3523789
    [No Abstract]   [Full Text] [Related]  

  • 37. Water-soluble contrast medium in the localisation of cord and dural stab wounds.
    Sutton D; DeSilva RD
    Clin Radiol; 1984 Nov; 35(6):483-4. PubMed ID: 6499389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide.
    Skalpe IO
    Acta Radiol Suppl; 1977; 355():359-70. PubMed ID: 400906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prophylactic use of phenytoin during iopamidol contrast studies of the subarachnoid space.
    de Vane PJ; Macpherson P; Teasdale E; Volo G; Casey M; Kelly JC; Whiting B
    Eur J Clin Pharmacol; 1986; 29(6):747-9. PubMed ID: 3709621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [-Cervical myelography using the lumbar route-].
    Parlier-Cuau C; Wybier M; Moutounet L; Champsaur P; Laredo JD
    Ann Radiol (Paris); 1997; 40(2):99-103. PubMed ID: 9754339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.